Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Digital Cognitive Training in Older Adults

11 novembre 2026 mis à jour par: Jihye Jung

Effect of a Physical Acticity-Integrated Digital Cognitive Training Program on Cognitive Function and Physical Performance in Community-Dwelling Older Adults

The purpose of this clinical study is to evaluate the effects of a digital cognitive training program combined with physical activity on the cognitive and physical functions of community-dwelling older adults. For older adults, maintaining both mental and physical health is essential for overall well-being. This study hypothesizes that combining tablet-based brain exercises with short, physical activities will help improve participants' memory, thinking skills, and physical abilities, such as balance and walking.

Researchers aim to enroll approximately 35 community-dwelling older adults who are 65 years of age or older and capable of walking. Participants will be randomly assigned to one of two groups:

  1. Standard Intervention Group: Participants will attend a 50-minute session once a week for 10 weeks. During each session, they will use a tablet device for cognitive training focused on memory, attention, and executive functions. This training will be paused three times per session for about 3 minutes each to perform low-intensity, physical activities to music.
  2. Extended Intervention Group: Participants will participate in the same 10-week digital cognitive training and physical activity program as the standard group. In addition, they will receive additional home-based cognitive activities to complete once a week.

To measure the effectiveness of the program, researchers will assess all participants before the program starts and after the 10-week program ends. Assessments will evaluate cognitive function, including memory and attention, as well as physical functions, such as grip strength, leg strength, balance, walking speed, and muscle mass.

Aperçu de l'étude

Type d'étude

Interventionnel

Inscription (Estimé)

35

Phase

  • N'est pas applicable

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

65 ans et plus (Adulte plus âgé)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Community-dwelling older adults aged 65 years or older.
  • Able to understand the purpose of the study and voluntarily consent to participate.
  • Cognitively intact or presenting with mild subjective memory complaints without a diagnosis of dementia (e.g., MoCA score ≥ 23 or MMSE score ≥ 24).
  • Able to walk independently without assistance (with or without assistive devices).
  • Able to understand instructions and perform cognitive and physical training programs using digital devices.

Exclusion Criteria:

  • Diagnosis of dementia or severe cognitive impairment.
  • Severe visual or hearing impairment that interferes with participating in digital training or assessment.
  • Acute or chronic neurological/musculoskeletal disorders that limit physical training (e.g., recent stroke, severe osteoarthritis).
  • History of severe cardiovascular disease or unmanaged hypertension/diabetes.
  • Current participation in other interventional clinical trials or similar cognitive/physical training programs.
  • Inability to follow study instructions due to severe psychiatric illness or communication difficulties.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: La prévention
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Comparateur actif: Standard Intervention Group

Participants will receive a 50-minute session consisting of tablet-based digital cognitive training combined with physical activities once a week for 10 weeks.

A 10-week program where participants attend a 50-minute session once a week. Each session involves tablet-based digital cognitive training (focusing on memory, attention, and executive functions) combined with three 3-minute bouts of low-intensity, physical activities.

Expérimental: Extended Intervention Group

Participants will receive the same 10-week program as the Standard Intervention Group (tablet-based digital cognitive training and seated physical activities). In addition, they will receive home-based cognitive activities to complete once a week.

A 10-week program combining a once-weekly 50-minute center-based session (tablet-based cognitive training and seated physical activities) with additional home-based cognitive activities to be completed once a week.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
The Korean Version of Montreal Cognitive Assessment (MoCA-K)
Délai: Baseline and 10 weeks

Cognitive function will be assessed using the Korean version of the Montreal Cognitive Assessment (MoCA-K). Total scores range from 0 to 30, where higher scores indicate better cognitive performance.

Baseline and 10 weeks

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
The Short Physical Performance Battery (SPPB).
Délai: Baseline and 10 weeks

Overall physical performance will be assessed using the Short Physical Performance Battery (SPPB). The SPPB evaluates lower extremity function through three components: standing balance, gait speed, and a 5-repetition chair stand test. Each component is scored from 0 to 4, yielding a total score ranging from 0 to 12. Higher scores indicate better physical function.

Baseline and 10 weeks
Change in Grip Strength
Délai: Baseline and 10 weeks

Handgrip strength will be measured using a hand dynamometer. Results are recorded in kilograms (kg), where higher values indicate greater upper body muscle strength.

Baseline and 10 weeks
Change in Lower Extremity Strength
Délai: Baseline and 10 weeks

Lower body strength will be assessed using the Five-times Sit-to-Stand test. Scores indicate the seconds of stands completed in 5 times, where a higher number indicates better lower extremity strength.

Baseline and 10 weeks
Change in Dynamic Balance
Délai: Baseline and 10 weeks

Dynamic balance will be assessed using the Timed Up and Go (TUG) test. Results are measured in seconds, where a lower time indicates better mobility and dynamic balance.

Baseline and 10 weeks
Change in Static Balance
Délai: Baseline and 10 weeks

Static balance will be assessed using the Balancia software by measuring COP sway path length under the eyes open and closed condition. Results are recorded in centimeters (cm), where lower values indicate better postural stability.

Baseline and 10 weeks
Change in Gait velocity
Délai: Baseline and 10 weeks

Gait velocity will be assessed using the GAITRite electronic walkway system. Results are measured in centimeters per second (cm/s), where higher values indicate better walking performance.

Baseline and 10 weeks
Change in Gait cadence
Délai: Baseline and 10 weeks

Gait cadence will be assessed using the GAITRite electronic walkway system. Results are measured in steps per minute (steps/min), where higher values indicate better gait rhythm and coordination.

Baseline and 10 weeks
Change in Step Length
Délai: Baseline and 10 weeks

Step length will be assessed using the GAITRite electronic walkway system. Results are measured in centimeters (cm), where higher values indicate better gait efficiency.

Baseline and 10 weeks
Change in Stride Length
Délai: Baseline and 10 weeks

Stride length will be assessed using the GAITRite electronic walkway system. Results are measured in centimeters (cm), where higher values indicate better mobility.

Baseline and 10 weeks
Change in Skeletal Muscle Mass Index (SMI)
Délai: Baseline and 10 weeks

Skeletal Muscle Mass Index (SMI) will be assessed using a Bioelectrical Impedance Analysis (BIA) device (InBody BWA). SMI is reported in kg/m², where higher values indicate greater skeletal muscle mass.

Baseline and 10 weeks
Change in Subjective Memory Complaints (SMCQ-K)
Délai: Baseline and 10 weeks

Subjective memory complaints will be assessed using the Subjective Memory Complaints Questionnaire (SMCQ-K). Scores range from 0 to 14, where higher scores indicate a higher level of subjective memory impairment.

Baseline and 10 weeks
Change in Pain Intensity (NPRS)
Délai: Baseline and 10 weeks

Pain intensity will be measured using the Numeric Pain Rating Scale (NPRS) for participants reporting pain. Scores range from 0 (no pain) to 10 (worst possible pain), where lower scores indicate reduced pain intensity.

Baseline and 10 weeks

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

1 novembre 2026

Achèvement primaire (Estimé)

1 février 2027

Achèvement de l'étude (Estimé)

1 février 2027

Dates d'inscription aux études

Première soumission

5 novembre 2026

Première soumission répondant aux critères de contrôle qualité

11 novembre 2026

Première publication (Réel)

17 novembre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

17 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

11 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • SYU 2026-09-027-002

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner